Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca COVID-19 vaccine authorised for emergency use by the World Health Organization
-
Full-year 2020 results
-
AstraZeneca and IDT Biologika sign letter of intent to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity
-
Divestment of Crestor in Europe to Grünenthal completed
-
Update on KESTREL Phase III trial of Imfinzi with or without tremelimumab in the 1st-line treatment of recurrent or metastatic head and neck cancer
-
Forxiga approved in China for heart failure
-
COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials
-
AstraZeneca agrees to divest Viela shareholding
-
COVID-19 Vaccine AstraZeneca authorised for use in the EU
-
COVID-19 Vaccine AstraZeneca recommended for use in the EU
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here